VC
AMED

Veracity Capital’s Amedisys AMED Stock Holding History

Veracity Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,281
Closed -$559K – 254
2021
Q2 		$559K Sell
2,281
-3,277
-59% -$860K 0.13% 137
2021
Q1 		$1.47M Buy
5,558
+528
+10% +$149K 0.31% 87
2020
Q4 		$1.48M Buy
+5,030
New +$1.29M 0.37% 85

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Veracity Capital's AMED Position: Q3 2021 in Review

Veracity Capital sold out of Amedisys (AMED) in Q3 2021, closing a stake of 2,281 shares — an estimated $559K sold.

Veracity Capital first reported a position in AMED in Q4 2020 and held it in 3 quarters. The position peaked at $1.48M in Q4 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Veracity Capital reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Veracity Capital sold 2,281 Amedisys shares in Q3 2021, an estimated $559K.
  • Veracity Capital first reported a position in Amedisys in Q4 2020 and held it in 3 quarters.
  • Veracity Capital's Amedisys position peaked at $1.48M in Q4 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Veracity Capital's 13F filing for Q3 2021, filed 13 Oct 2021.